Garry Whitehead

465 total citations
5 papers, 378 citations indexed

About

Garry Whitehead is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Physiology. According to data from OpenAlex, Garry Whitehead has authored 5 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 2 papers in Behavioral Neuroscience and 2 papers in Physiology. Recurrent topics in Garry Whitehead's work include Neuroscience and Neuropharmacology Research (4 papers), Stress Responses and Cortisol (2 papers) and Alzheimer's disease research and treatments (2 papers). Garry Whitehead is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Stress Responses and Cortisol (2 papers) and Alzheimer's disease research and treatments (2 papers). Garry Whitehead collaborates with scholars based in United Kingdom and South Korea. Garry Whitehead's co-authors include Lynda M. Sanders, G.I. McRae, Kwangwook Cho, Daniel J. Whitcomb, Philip Regan, Thomas M. Piers, Jihoon Jo, Eunjoon Kim, Dong-Hyun Kim and Priyanka Narayan and has published in prestigious journals such as Brain, Scientific Reports and Journal of Pharmaceutical Sciences.

In The Last Decade

Garry Whitehead

5 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Garry Whitehead United Kingdom	5	173	98	98	65	51	5	378
A.A. Kamensky Russia	12	117 0.7×	114 1.2×	104 1.1×	40 0.6×	27 0.5×	53	374
Akiko Nakatani Japan	9	129 0.7×	146 1.5×	59 0.6×	15 0.2×	43 0.8×	9	423
Tamara Timić Stamenić United States	11	223 1.3×	140 1.4×	48 0.5×	30 0.5×	15 0.3×	30	445
Eugene Zubkov Russia	12	80 0.5×	103 1.1×	70 0.7×	24 0.4×	24 0.5×	46	417
Teodoro Zornoza Spain	13	261 1.5×	147 1.5×	46 0.5×	92 1.4×	18 0.4×	28	543
Anita Kurunczi Hungary	9	82 0.5×	67 0.7×	67 0.7×	81 1.2×	15 0.3×	10	357
Federica Geraci Italy	11	70 0.4×	110 1.1×	78 0.8×	42 0.6×	10 0.2×	16	422
Olga Abramova Russia	11	38 0.2×	83 0.8×	55 0.6×	26 0.4×	25 0.5×	38	379
Valeriya Ushakova Russia	10	43 0.2×	159 1.6×	88 0.9×	26 0.4×	21 0.4×	29	404
Mehdi Rezayat Iran	16	258 1.5×	184 1.9×	119 1.2×	10 0.2×	19 0.4×	27	531

Countries citing papers authored by Garry Whitehead

Since Specialization

Citations

This map shows the geographic impact of Garry Whitehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Whitehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Whitehead more than expected).

Fields of papers citing papers by Garry Whitehead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Whitehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Whitehead. The network helps show where Garry Whitehead may publish in the future.

Co-authorship network of co-authors of Garry Whitehead

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Whitehead. A scholar is included among the top collaborators of Garry Whitehead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Whitehead. Garry Whitehead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Yi, Jee Hyun, Christopher Brown, Garry Whitehead, et al.. (2017). Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus. Pharmacological Research. 121. 42–51. 29 indexed citations

2.

Whitehead, Garry, Philip Regan, Daniel J. Whitcomb, & Kwangwook Cho. (2016). Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease. Neuropharmacology. 112(Pt A). 221–227. 54 indexed citations

3.

Whitcomb, Daniel J., Philip Regan, Thomas M. Piers, et al.. (2015). Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus. Scientific Reports. 5(1). 10934–10934. 90 indexed citations

4.

Whitehead, Garry, Jihoon Jo, Thomas M. Piers, et al.. (2013). Acute stress causes rapid synaptic insertion of Ca2+-permeable AMPA receptors to facilitate long-term potentiation in the hippocampus. Brain. 136(12). 3753–3765. 77 indexed citations

5.

Sanders, Lynda M., et al.. (1986). Prolonged Controlled-Release of Nafarelin, a Luteinizing Hormone-Releasing Hormone Analogue, from Biodegradable Polymeric Implants: Influence of Composition and Molecular Weight of Polymer. Journal of Pharmaceutical Sciences. 75(4). 356–360. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact